{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:22Z","timestamp":1786984342251,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.annder.2011.01.005","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T04:27:19Z","timestamp":1297398439000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dermatite herp\u00e9tiforme\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"138","author":[{"given":"S.","family":"Ingen-Housz-Oro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2011.01.005_bib0005","first-page":"434","article-title":"Prospective analysis of the incidence of auto-immune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2011.01.005_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/gut.25.2.151","article-title":"Dermatitis herpetiformis: diagnosis, diet and demography","volume":"25","author":"Gawkrodger","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.annder.2011.01.005_bib0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0738-081X(00)00184-X","article-title":"Dermatitis herpetiformis","volume":"19","author":"Reunala","year":"2001","journal-title":"Clin Dermatol"},{"issue":"7476","key":"10.1016\/j.annder.2011.01.005_bib0020","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0140-6736(66)91692-8","article-title":"Small-bowell changes in dermatitis herpetiformis","volume":"2","author":"Marks","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2011.01.005_bib0025","first-page":"441","article-title":"Practical management of the most common auto-immune bullous diseases","volume":"99","author":"Suarez-Fernandez","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.annder.2011.01.005_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1399-0039.1997.tb02706.x","article-title":"Dermatitis herpetiformis and celiac disease are both primarily associated with HLA-DQ [alpha 1*0501, beta I*02] or the HLA-DQ [alpha 1*03, beta 1*0302] heterodimers","volume":"49","author":"Spurkland","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.annder.2011.01.005_bib0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2133.1996.tb16220.x","article-title":"Incidence of familial dermatitis herpetiformis","volume":"134","author":"Reunala","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0040","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1046\/j.1523-1747.2000.00172.x","article-title":"Concordance of dermatitis herpetiformis and celiac disease in monozygotic twins","volume":"115","author":"Hervonen","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognised by gut derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.annder.2011.01.005_bib0050","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.annder.2008.02.030","article-title":"Physiopathologie de la dermatite herp\u00e9tiforme. Donn\u00e9es actuelles","volume":"135","author":"Doffoel-Hantz","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.005_bib0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000073710","article-title":"Pathomechanisms in celiac disease","volume":"132","author":"Dieterich","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.annder.2011.01.005_bib0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase\u00a03) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Sardy","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.annder.2011.01.005_bib0065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen in celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.annder.2011.01.005_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1357-2725(01)00033-4","article-title":"Analysis of epidermal-type transglutaminase (TGase\u00a03) expression in mouse tissues and cell lines","volume":"33","author":"Hitomi","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.annder.2011.01.005_bib0075","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI200421055","article-title":"A new model for dermatitis herpetiformis that uses HLA-DQ8\u00a0transgenic NOD mice","volume":"114","author":"Marietta","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2011.01.005_bib0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02944243","article-title":"Dermatitis herpetiformis: a review of 54\u00a0patients","volume":"166","author":"Egan","year":"1997","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.annder.2011.01.005_bib0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2230.1982.tb02489.x","article-title":"The treatment of dermatitis herpetiformis","volume":"7","author":"Fry","year":"1982","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2133.2004.05642.x","article-title":"The occurrence of type\u00a01\u00a0diabetes in patients with dermatitis herpetiformis and their first-degree relatives","volume":"150","author":"Hervonen","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1997.tb14935.x","article-title":"Diseases associated with dermatitis herpetiformis","volume":"136","author":"Reunala","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","article-title":"Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience","volume":"46","author":"Alonso-Llamazares","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0105","first-page":"52331","article-title":"Dermatitis herpetiformis: problems, progress and prospects","volume":"12","author":"Fry","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0110","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archderm.1996.03890320060010","article-title":"Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis","volume":"132","author":"Zone","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/bmj.1.6065.872","article-title":"Dermatitis herpetiformis: effect of gluten-free diet on skin IgA and jejunal structure and function","volume":"1","author":"Harrington","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2011.01.005_bib0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","article-title":"Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.jid.5701041","article-title":"Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue","volume":"128","author":"Marietta","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPG.0b013e3181a81384","article-title":"Prediction of clinical nd mucosal severity of celiac disease and dermatitis herpetiformis by quantification of IgA\/IgG serum antibodies to tissue transglutaminase","volume":"50","author":"Dahlbom","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.annder.2011.01.005_bib0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archderm.1987.01660330090016","article-title":"Reticulin and endomysial antibodies in bullous diseases","volume":"123","author":"Kumar","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0140","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/archderm.1992.01680210052006","article-title":"Serologic markers of gluten-sensitive enteropathy in bullous diseases","volume":"128","author":"Kumar","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0145","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.3748\/wjg.v12.i41.6585","article-title":"Celiac disease","volume":"12","author":"Rodrigo","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.annder.2011.01.005_bib0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2133.1994.tb08557.x","article-title":"Twenty-five years\u2019 experience of a gluten-free diet in the treatment of dermatitis herpetiformis","volume":"131","author":"Garioch","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2133.1993.tb03516.x","article-title":"Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study","volume":"129","author":"Swerdlow","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0160","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.38.4.528","article-title":"Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease","volume":"38","author":"Collin","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.annder.2011.01.005_bib0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.308.6920.13","article-title":"Risk of lymphoma in patients with dermatitis herpetiformis","volume":"308","author":"Sigurgeirsson","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2011.01.005_bib0170","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dld.2006.03.002","article-title":"Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study","volume":"38","author":"Viljamaa","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.annder.2011.01.005_bib0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2133.2005.06345.x","article-title":"Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives","volume":"152","author":"Hervonen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2133.1996.tb01496.x","article-title":"Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis","volume":"135","author":"Lewis","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0185","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2036.2008.03660.x","article-title":"No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study","volume":"27","author":"Lewis","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annder.2011.01.005_bib0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0195","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0151-9638(04)93842-2","article-title":"Disulone","volume":"131","author":"Begon","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.005_bib0200","first-page":"146","article-title":"The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis","volume":"36","author":"Sanders","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.annder.2011.01.005_bib0205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1990.01670310081011","article-title":"The incidence of agranulocytosis during tretment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972\u00a0through 1988","volume":"126","author":"H\u00f6rnsten","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1440-0960.2005.00152.x","article-title":"Sulfasalazine and dermatitis herpetiformis","volume":"46","author":"Willsteed","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2230.2000.00615.x","article-title":"Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide","volume":"25","author":"Shah","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.59.6.517","article-title":"Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet","volume":"59","author":"Reunala","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.annder.2011.01.005_bib0225","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.2003.05579.x","article-title":"Long-term remission in patients with dermatitis herpetiformis on a normal diet","volume":"149","author":"Bardella","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.005_bib0230","unstructured":"Recherche d\u2019anticorps dans la maladie c\u0153liaque\u00a0: diagnostic et suivi du r\u00e9gime sans gluten. Recommandations HAS, 2007. www.snfge.asso.fr."}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381100010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381100010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:57:30Z","timestamp":1758970650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S015196381100010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S015196381100010X"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.005","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatite herp\u00e9tiforme\u00a0: revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}